SafeHeal

Executive Summary

SafeHeal is a Paris-based clinical-stage medical device company founded in 2015, focused on improving outcomes in colorectal surgery. Its lead product, Colovac, is an anastomosis protection device designed to reduce fecal contact at the surgical connection site, thereby preventing leaks and potentially eliminating the need for a diverting ostomy. The company is currently in Phase 1 clinical development and has not yet commercialized any product. SafeHeal addresses a significant unmet need, as anastomotic leaks occur in up to 20% of colorectal surgeries, leading to high morbidity, mortality, and healthcare costs.

Upcoming Catalysts (preview)

• Q4 2026Completion of Phase 1 Clinical Trial with Positive Safety Data75% success
• Q1 2027Submission for CE Mark Approval65% success
• Q2 2027Series B Financing Round to Fund Pivotal Trials70% success